LONDON -- When weighing up a potential investment, we always need to look forward rather than backward.
If you buy a stake in a business, it's the future profits that count -- and the stock market will value your shares based on future expectations.
With that in mind, it can be helpful to review what expert City analysts are expecting a company to earn in the coming years. These expectations can then be compared to the share price to give you a better idea of how the stock market is valuing the business.
Today, I'm looking at the earnings per share forecasts for�AstraZeneca� (LSE: AZN ) (NYSE: AZN ) , the FTSE 100 pharmaceutical giant. All my figures are courtesy of S&P Capital IQ.
Analysts expect AstraZeneca's profits to be 3.34 pounds per share this year. This estimate means that, compared to today's share price of 3,296 pence, the market is valuing AstraZeneca's shares on a forward price-to-earnings multiple of 9.8.
Looking ahead, the consensus then calls for a further decline in AstraZeneca's earnings to 3.19 pounds per share for 2014, before slipping to 3.15 pounds in 2015. The data also indicates that AstraZeneca's revenues might shrink by almost 7% a year over the same time period, from $30 billion to around $24.7 billion.
Hot Up And Coming Companies To Own For 2016: (LTUM)
Lithium Corporation, an exploration stage company, engages in the identification, acquisition, and exploration of metals and minerals with a focus on lithium mineralization in Nevada. It holds interests in Fish Lake Valley property that covers approximately 7,360 acres located in west central Nevada in northern Esmeralda County; Salt Wells property, which covers approximately 8,500 acres in Churchill County; and Cortez property that consists of approximately 4,960 acres located in Lander County, Nevada. The company was formerly known as Utalk Communications Inc. and changed its name to Lithium Corporation in September 2009. Lithium Corporation was founded in 2007 and is based in Reno, Nevada.
Advisors' Opinion:- [By CRWE]
Today, LTUM has shed (-19.80%) down -0.0079 at $.0320 with 33,100 shares in play thus far (ref. google finance Delayed: 11:18AM EDT June 26, 2013), but don�� let this get you down.
Location Based Technologies, Inc. previously reported it received FCC and IC certification for its versatile LBT-886 device. These certifications are necessary before devices can be sold to consumers throughout the US and Canada.
Lithium Corporation previously reported it has recently acquired a new Graphite (BC Sugar) prospect in the Shuswap area of British Columbia, in an under-explored area. In addition to the acquired claim, Lithco has also staked another four claims, to bring the total area to be explored by the Company to 3,405.77 acres (1,378.27 hectares). Although graphite has been identified locally in marbles, it has become apparent that graphite is also hosted here in quartz, biotite/mica gneisses, and also in calc-silicate gneisses. The host rocks at BC Sugar are similar to the host rocks in the area of the Crystal Graphite deposit 55 miles (90 kms) to the Southeast, where Lithium Corporation holds the Mt Heimdal block of claims.
Hot Up And Coming Companies To Own For 2016: ITV PLC (ITV)
ITV Public Company Limited (ITV) is a commercial television network in the United Kingdom. t also delivers content across multiple platforms either directly or through itv.com and ITV Player. It has two segments: ITV Studios and Broadcasting & Online��segment. Its broadcasting and online segment is responsible for commissioning and scheduling programs on the ITV channels, marketing and program publicity and online rights exploitation. It derives its revenue primarily from the sale of advertising airtime and sponsorship, and other sources of revenue are from participation revenue, online advertising and the digital terrestrial multiplex, SDN. ITV Studios is an international productions business. In February 2014, ITV Plc acquired a controlling stake in DiGa Vision, the New York based independent producer of reality and scripted programming including Teen Wolf. Advisors' Opinion:- [By Jonathan Morgan]
ITV Plc (ITV) increased 3.7 percent to 134.2 pence, the biggest advance since February. Liberum Capital upgraded its price estimate on the U.K. broadcaster�� shares to 200 pence from 155 pence, citing ��tructurally resilient��free-to-air television advertisements and forecast growth in online and content revenue.
Top Diversified Bank Stocks To Invest In 2016: Trinity Industries Inc.(TRN)
Trinity Industries, Inc. provides products and services to the industrial, energy, transportation, and construction sectors primarily in the United States, Canada, Mexico, the United Kingdom, Singapore, and Sweden. The company?s Rail Group manufactures and sells railcars, including auto carrier, box, gondola, hopper, intermodal, specialty, and tank cars; and railcar components, such as couplers and axles. This group also offers repair and coating services. It primarily serves railroads, leasing companies, and industrial shippers of various products. Trinity Industries? Railcar Leasing and Management Services group leases tank cars and freight cars to industrial shippers and railroads operating in petroleum, chemical, agricultural, and energy industries with a fleet of 54,595 owned or leased railcars; provides management and administrative services; and manages railcar fleets on behalf of third parties. The company?s Construction Products group produces ready mix concret e; produces and distributes construction aggregates, including crushed stone, sand and gravel, asphalt rock, and specialty sands and gravel; manufactures highway products and other steel products for infrastructure related projects; supplies ready mix concrete; and provides hot-dip galvanizing services for fabricated steel materials. It primarily serves contractors and subcontractors in the construction and foundation industry. Trinity Industries? Inland Barge group manufactures inland barges; and fiberglass reinforced lift covers. It serves commercial marine transportation companies. The company?s Energy Equipment group manufactures structural wind towers, tank containers, and tank heads for pressure vessels; fertilizer containers; and tank heads for non-pressure vessels, LPG tanks, and utility, traffic, and lighting structures. It serves turbine producers, as well as industrial plants, utilities, residences, and small businesses. The company was founded in 1933 and is he adquartered in Dallas, Texas.
Advisors' Opinion:- [By Holly LaFon]
Another area that is intriguing to us is the North American energy sector which looks to have a number of interesting catalysts currently. While the energy sector is at present only a modest overweight in the portfolios, we have been encouraged by several trends taking place for a number of years. These positive developments are also having an impact that goes far beyond the energy sector itself. Many believe that the U.S. will become energy independent and possibly a net exporter of natural gas and oil (currently restricted by law) in the next decade. This opinion is based primarily on the development of new drilling techniques (i.e. horizontal drilling, and high pressure fracking) that have enabled companies to access oil and natural gas reserves in shale formations that were previously not economically viable. The ability to tap into this acreage is a game-changer in our view and is already having a tremendous impact on the economy. Employment rates in these mostly rural areas surrounding the shale basins are very high and companies thus find hiring extremely competitive. Strong labor markets tend to create strong local economies. Oil States International (OIS) has been able to capitalize on this trend by providing housing and other services to oil service workers that are in demand in the area. CST Brands (CST) operates gas stations in Texas, but it is increasingly looking to broaden its product offering beyond fuel. Rail companies like Union Pacific (UNP), Canadian Pacific (CP), Kansas City Southern (KSU) and Genesee and Wyoming (GWR) have also benefited substantially. Given that shale areas are rural and often lacking infrastructure, substantial investment must be made to support drilling and production activities. Without pipelines in place, railroads have been the primary takeaway mechanism for moving production to the various clusters of refining capacity around the United States. In order to serve this demand, massive investment in railcars has been nee
- [By Vera Yuan]
��ailroad service company Trinity Industries, Inc. (TRN) reported better than expected revenue and profitability based on continued strength in demand for tank cars coupled with a meaningful positive impact from a large new customer (Element Financial).
- [By cody56]
The fund in the third quarter letter discuss its best holdings which included medical device manufacturer Natus Medical Inc. (BABY), rail road service company Trinity Industries Inc. (TRN), resort operator Vail Resorts Ince (MTN), Correction Corp Of America (CXW), and Endurance Specialty Holdings Ltd. (ENH).
- [By Aaron Levitt]
Finally, any new tank-car regulation will benefit those firms that actually build and supply all those new cars. So our last pick in the wide world of railroad stocks is�Trinity Industries (TRN). The firm already has seen its tank-car order backlog surge so much — currently sitting at 40,000 cars — that it has shifted much of its capacity at its wind turbine tower business towards the manufacture of rail cars.
Hot Up And Coming Companies To Own For 2016: Crumbs Bake Shop Inc (CRMB)
Crumbs Bake Shop, Inc., formerly 57th Street General Acquisition Corp., incorporated on October 29, 2009, is owner of Crumbs Holdings LLC (Crumbs), a neighborhood bakery and a retailer of cupcakes. As of November 1, 2011, Crumbs had 43 locations, including 29 locations in the New York Metro area, nine locations on the West Coast, three locations in Washington, D.C., one location in Virginia and one location in Chicago. The specialty of the house is cupcakes; however, the menu also includes a blend of baked goods. On May 5, 2011, the Company merged with Crumbs.
The Company offers a range of Signature and Taste size cupcakes. Signature cupcakes are ordered in increments of six. One can create its own individual six packs or choose a pre-selected assortment. Its Taste size cupcakes are offered by the dozen in pre-selected favorites assortments. There are more than 60 varieties of cupcakes baked fresh daily with a new cupcake of the week debuting each Monday.
Advisors' Opinion:- [By Lex Haris]
Crumbs (CRMB) closed all of its stores Monday, and has been struggling for some time. It began closing outlets in 2013 amid steep losses. At the end of the first quarter this year, it had 65 locations in 12 states.
- [By Jack Kramer and Nick Martell]
2. Crumbs Cupcake stock continues to drop
Pour some sugar on me, baby, because the recent performance of cupcake-makin' chain Crumbs Bake Shop (NASDAQ: CRMB ) hasn't tasted good for investors. The stock has fallen nearly 30% in the past month, dropped 13.4% in the last week, and dipped almost 2% Monday on growing doubts the company can even stay in business.
Hot Up And Coming Companies To Own For 2016: Acceleron Pharma Inc (XLRN)
Acceleron Pharma Inc., incorporated on June 13, 2003, is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of protein therapeutics for cancer and rare diseases. The Company�� research focuses on the biology of the Transforming Growth Factor-Beta (TGF-b) protein superfamily, a large and diverse group of molecules that are key regulators in the growth and repair of tissues throughout the human body. By coupling its discovery and development expertise, including its knowledge of the TGF-b superfamily, with its internal protein engineering and manufacturing capabilities, it has built a productive research and development platform that has generated clinical and preclinical protein therapeutic candidates with mechanisms of action.
The Company focuses on discovering and developing protein therapeutics that target a group of approximately 30 secreted proteins, or ligands, that are collectively referred to as the TGF-b superfamily. These ligands bind to subsets of 12 different receptors on the surface of cells, triggering intra-cellular changes in gene expression that guide cell growth and differentiation. The TGF-b superfamily ligands and their receptors represent an under-explored and diverse set of drug targets with the potential to yield therapeutics that modulate the growth and repair of diseased cells and tissues.
The Company has three internally discovered protein therapeutic candidates that are being studied in 12 ongoing Phase 2 clinical trials, focused on cancer and rare diseases. The Company�� two advanced protein therapeutic candidates, sotatercept and ACE-536, promote red blood cell production through a novel mechanism. Together with its collaboration partner, Celgene Corporation, the Company is developing sotatercept and ACE-536 to treat anemia and associated complications in patients with b-thalassemia and myelodysplastic syndromes (MDS). These red blood cell disorders are generally unresponsive to approved dru! gs. The Company�� third clinical stage protein therapeutic candidate, dalantercept, is designed to inhibit blood vessel formation through a mechanism that is distinct from, and potentially synergistic with, the dominant class of cancer drugs that inhibit blood vessel formation, the vascular endothelial growth factor (VEGF) pathway inhibitors. The Company is developing dalantercept primarily for use in combination with these products to produce better outcomes for cancer patients.
The Company and Celgene have conducted six human clinical trials with sotatercept in over 160 healthy volunteers and cancer patients. The Company has conducted one clinical trial with ACE-536 in healthy volunteers. In these studies, both sotatercept and ACE-536 caused a dose-dependent increase in the number of red blood cells. Based on these results, the Company and Celgene have initiated Phase II clinical trials with each of these protein therapeutic candidates in b-thalassemia and MDS. In the ongoing trial of sotatercept in patients with b-thalassemia, the Company has observed encouraging, dose-dependent increases in hemoglobin in a subset of patients at the two lowest dose levels.
Sotatercept is a soluble receptor fusion protein consisting of the extracellular domain of the activin receptor type IIA (ActRIIA) linked to the Fc domain of human IgG1. Sotatercept acts as a protein trap for TGF-b superfamily ligands that signal through the ActRIIA receptor. Sotatercept has increased red blood cells in multiple clinical trials. ACE-536 is a soluble receptor fusion protein consisting of a modified extracellular domain of the activin receptor type IIB (ActRIIB) linked to the Fc domain of human IgG1.
Advisors' Opinion:- [By John Udovich]
The biotech sector has been pretty exciting this year�with small cap biotech stocks Prana Biotechnology Limited (NASDAQ: PRAN) and TNI BioTech (OTCMKTS: TNIB) having recently produced noteworthy news for investors�while Acceleron Pharma, Inc (NASDAQ: XLRN), Ophthotech (NASDAQ: OPHT) and BIND Therapeutics (NASDAQ: BIND) have just�set term sheets for their upcoming IPOs. Just consider all of the following recent news:
- [By Monica Gerson]
Breaking news
Acceleron Pharma (NASDAQ: XLRN) today announced that it has commenced an underwritten public offering of $100 million of its common stock. To read the full news, click here. XenoPort (NASDAQ: XNPT) announced today that it intends to offer and sell 10,000,000 shares of its common stock, subject to market and other conditions, in an underwritten public offering. To read the full news, click here. Affymetrix (NASDAQ: AFFX) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its CytoScan庐 Dx Assay. To read the full news, click here. Verizon Communications (NYSE: VZ) and Intel (NASDAQ: INTC) today announced an agreement for Verizon to purchase from Intel the assets of Intel Media, a business division dedicated to the development of Cloud TV products and services. To read the full news, click here.Posted-In: Evercore Partners US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets
- [By Ben Levisohn]
3. We see 23+ partnered pipeline assets and are most positive on Phase I/II MOR202 anti-CD38 for myeloma with data in 2015, and others such as Acceleron Pharma (XLRN), Agios Pharmaceuticals (AGIO), Epizyme (EPZM), Concert Pharmaceuticals (CNCE) (just started Phase I for next-gen Revlimid).
- [By Jake L'Ecuyer]
Shares of Acceleron Pharma (NASDAQ: XLRN) got a boost, shooting up 16.74 percent to $39.54 after Form 8-K for Acceleron Pharma showed that Celgene (NASDAQ: CELG) will buy 1.1 million shares for $47.15 million.
Hot Up And Coming Companies To Own For 2016: Kayne Anderson Energy Total Return Fund Inc (KYE)
Kayne Anderson Energy Total Return Fund, Inc. (the Fund) is a non-diversified closed-end investment company. The Fund�� investment objective is to obtain a high total return with an emphasis on current income. The Fund seeks to achieve this objective by investing primarily in securities of companies engaged in the energy industry, principally including publicly-traded energy-related master limited partnerships and limited liability companies taxed as partnerships (MLPs), MLP affiliates, energy-related United States and Canadian royalty trusts and income trusts and other companies that derive at least 50% of their revenues from operating assets used in, or providing energy-related services for, the exploration, development, production, gathering, transportation, processing, storing, refining, distribution, mining or marketing of natural gas, natural gas liquids (including propane), crude oil, refined petroleum products or coal.
Effective December 31, 2006, Kayne Anderson assigned the Investment Management Agreement to its subsidiary, KA Fund Advisors, LLC (the Adviser). The Fund focuses on investing at least 80% of the aggregate of its net assets and borrowings (total assets) in securities of Energy Companies. The Fund invests in equity securities, such as common stocks, preferred stocks, convertible securities, warrants, depository receipts, and equity interests in MLPs, MLP affiliates, royalty trusts and other Energy Companies.
Advisors' Opinion:- [By Robert Rapier]
We got several questions about Kayne Anderson Energy Total Return Fund (NYSE: KYE) during the chat. The main advantage of closed-end MLP funds is the diversification they provide, along with the convenience of a 1099 miscellaneous income tax form instead of having to deal with K-1 forms from each individual MLP. This makes a closed-end MLP fund a more attractive option for an IRA.
No comments:
Post a Comment